Literature DB >> 11745347

IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma.

M R Woolhiser1, Y Okayama, A M Gilfillan, D D Metcalfe.   

Abstract

It has been reported that FcgammaRI is up-regulated on human mast cells (huMC) by IFN-gamma and aggregation of this receptor using mouse F(ab')(2) specific for receptor-bound, mouse anti-CD64 F(ab')(2) results in activation. To determine whether huMC can similarly be stimulated by aggregation of FcgammaRI-bound human IgG, IFN-gamma-treated, CD34(+)-derived, cultured huMC were sensitized with human immunoglobulins and activation was evaluated following addition of antibodies specific for each IgG isotype. Degranulation was also examined following simultaneous IgG- and IgE-dependent aggregation of FcgammaRI and Fc(epsilon)RI. Activation of IFN-gamma-treated huMC sensitized with 100 ng/ml IgG(1) resulted in 40% beta-hexosaminidase (beta-hex) release; minimal degranulation was observed using IgG(2), IgG(3) or IgG(4). IgG(1)-dependent activation led to PGD(2) and LTC(4) generation as well as elevated cytokine production, most notably TNF-alpha. Preincubation of cells with F(ab')(2) from CD64-specific clones 10.1 and 32.2 reduced IgG(1)-mediated beta-hex release by 46% and 74%, respectively. While IgG-dependent cell stimulation induced half-maximal degranulation by 11 min, IgE-dependent activation resulted in half maximal responses within 1 min. Simultaneous activation of huMC via FcgammaRI and Fc(epsilon)RI led to additive degranulation using suboptimal concentrations of IgG(1) and IgE. Activation of huMC thus may occur via monomeric IgG and FcgammaRI thereby providing a novel paradigm for huMC recruitment into inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745347     DOI: 10.1002/1521-4141(200111)31:11<3298::aid-immu3298>3.0.co;2-u

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

Review 1.  Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm.

Authors:  Jayapal Manikandan; Narasimhan Kothandaraman; Manoor Prakash Hande; Peter Natesan Pushparaj
Journal:  Cell Mol Life Sci       Date:  2011-12-07       Impact factor: 9.261

Review 2.  Leukocytes in glomerular injury.

Authors:  Stephen R Holdsworth; Peter G Tipping
Journal:  Semin Immunopathol       Date:  2007-10-16       Impact factor: 9.623

3.  Lipoteichoic acid improves the capability of mast cells in the host defense system against bacteria.

Authors:  Naoki Imajo; Daisuke Kurihara; Nobuyuki Fukuishi; Asumi Inukai; Shinobu Matsushita; Shingo Noda; Mako Toyoda; Mino Yoshioka; Hayato Teruya; Yumiko Nishii; Nobuaki Matsui; Masaaki Akagi
Journal:  Inflamm Res       Date:  2009-05-26       Impact factor: 4.575

Review 4.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity.

Authors:  Stephen J Galli; Michele Grimbaldeston; Mindy Tsai
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

5.  Early neoplastic progression is complement independent.

Authors:  Karin E de Visser; Lidiya V Korets; Lisa M Coussens
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

6.  An optimized protocol for the generation and functional analysis of human mast cells from CD34+ enriched cell populations.

Authors:  Yuzhi Yin; Yun Bai; Ana Olivera; Avanti Desai; Dean D Metcalfe
Journal:  J Immunol Methods       Date:  2017-06-16       Impact factor: 2.303

7.  Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype.

Authors:  Eunice Ching Chan; Yun Bai; Arnold S Kirshenbaum; Elizabeth R Fischer; Olga Simakova; Geethani Bandara; Linda M Scott; Laura B Wisch; Daly Cantave; Melody C Carter; John C Lewis; Pierre Noel; Irina Maric; Alasdair M Gilfillan; Dean D Metcalfe; Todd M Wilson
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

8.  Interferon-γ enhances both the anti-bacterial and the pro-inflammatory response of human mast cells to Staphylococcus aureus.

Authors:  Emily J Swindle; Jared M Brown; Madeleine Rådinger; Frank R DeLeo; Dean D Metcalfe
Journal:  Immunology       Date:  2015-10-05       Impact factor: 7.397

9.  Our perception of the mast cell from Paul Ehrlich to now.

Authors:  Michael A Beaven
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

Review 10.  Mast cell-orchestrated immunity to pathogens.

Authors:  Soman N Abraham; Ashley L St John
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.